Skip to Content

Top 5 Genetic Tests Every Clinical Laboratory Should Offer in 2025

In the era of personalized medicine, genetic testing is no longer a luxury it’s a clinical necessity. As the demand for faster, more precise, and preventive healthcare grows, laboratories must expand their test menus to stay relevant and competitive.

Whether you're a hospital lab, fertility clinic, or private diagnostic center, offering the right genetic panels can boost your clinical impact and attract more patients and partners.

So, what are the most important genetic tests to offer in 2025? Based on medical trends, market needs, and clinical relevance, here are the Top 5 must-have genetic tests for any modern laboratory.


BRCA1/2 and Hereditary Cancer Panels

Cancer genetics remains a top priority in diagnostic care.

Read more 

Mutations in the BRCA1 and BRCA2 genes significantly increase the risk of breast, ovarian, prostate, and other cancers. Offering hereditary cancer panels (including TP53, MLH1, PTEN, etc.) can support:

  • Early detection and prevention
  • Personalized cancer risk assessment
  • Informed treatment planning (e.g., PARP inhibitors)



Non-Invasive Prenatal Testing (NIPT)

NIPT has revolutionized prenatal care by providing safe, accurate, and early detection of fetal chromosomal abnormalities using a simple maternal blood sample.

Read more 

Key benefits:

  • Detects trisomies 21 (Down syndrome), 18, and 13


  • Optional screening for sex chromosome aneuploidies 


  • High sensitivity (>99%) and low false-positive rates


Pharmacogenetics Panels

As drug response varies by genetics, pharmacogenomic testing enables tailored prescriptions based on a patient’s DNA.

Read more 

Your lab should test for:

  • CYP2D6, CYP2C9, CYP3A5 (drug metabolism genes)
  • SLCO1B1 (statin tolerance)
  • VKORC1 (warfarin sensitivity)



Carrier Screening for Reproductive Health

Carrier screening identifies couples at risk of passing genetic disorders to their children. It's increasingly offered before or during pregnancy.

Read more 

Top conditions to screen for:

  • Cystic fibrosis (CFTR)


  • Thalassemia


  • Spinal muscular atrophy (SMA)


  • Fragile X syndrome


Comprehensive Newborn Genetic Screening

Traditional newborn screening is expanding to include next-generation sequencing (NGS)-based panels that detect dozens of treatable genetic disorders early.

Read more 

Benefits:

  • Improve life-long outcomes with early intervention
  • Identify metabolic, immunological, and neurological disorders
  • Reduce long-term healthcare costs

🧬 BGI’s NGS panels offer rapid turnaround and are optimized for neonatal use.

Conclusion: Is Your Lab Ready for 2025?

Genetic testing is transforming every medical specialty  from oncology to cardiology, fertility to neurology. By offering these 5 essential panels, your lab not only meets current clinical needs but also positions itself as a leader in genomic diagnostics.

With BGI's validated kits, reagents, and sequencing platforms, you can scale your genetic testing confidently and affordably.